• IgY antibody technology against SARS-CoV-2 unveiled PharmaSources.com
    February 18, 2022
    An IgY neutralizing antibody, which is claimed to inhibit the activity of SARS-CoV-2, the novel coronavirus that causes COVID-19, by over 99 percent, was launched in Shenzhen on Monday, according to Shenzhen Special Zone Daily.
PharmaSources Customer Service